Clinical and Experimental Health Sciences (Clin Exp Health Sci) is an international, scientific, open access journal published in accordance with independent, unbiased and double-blinded peer-review principles. The journal is the official publication of Marmara University Health Sciences Institute and it is published quarterly in a year on March, June, September and December. The journal publishes clinical, experimental research and survey articles, review articles, case reports, letters to the editor and editorial comments prepared in accordance with ethical guidelines in all disciplines of health sciences.



The journal publishes articles only written in English. Clinical and Experimental Health Sciences aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic health sciences.



All authors are required to follow the privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, has given written consent on the inclusion to the study. The authors are responsible for the scientific content of the material to be published, and should complete and save the Patient Consent Form and send to the journal if requested.



The editorial and publication processes of the journal are shaped in accordance with the guidelines of International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).



Originality, high scientific quality, and citation potential are the most important criteria for manuscript acceptation. Manuscripts submitted for evaluation should not have been previously published or submitted for publication elsewhere.

Manuscripts submitted to Clinical and Experimental Health Sciences will go through a double-blind peer-review process and will be reviewed by at least two external, independent peer reviewers who are experts in their fields. The Editor in Chief is the final authority in the decision-making process for all submissions.



An approval of research protocols by the Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, drug studies and case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors. For manuscripts concerning experimental research on humans, a statement that shows the written informed consent from participants was obtained following a detailed explanation of the experimental procedures should be included in the text. Likewise, for studies carried out on animals an ethical committee report should be stated. Information on consents, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript. It is the authors’ responsibility to carefully protect the participants’ anonymity. For photographs that may reveal the identity of the participants, signed releases of the participants or of their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate by CrossCheck, intihal.net TUBITAK). In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.



Each individual listed as an author should fulfill the authorship criteria suggested by the ICMJE authorship recommendations, which are;



1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work

2. Drafting the work or revising it critically for important intellectual content

3. Final approval of the version to be published

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.



All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged in the title page of the manuscript.



Clinical and Experimental Health Sciences requires corresponding authors to submit a signed and scanned version of the Authorship Contribution Form (available for download at https://dergipark.org.tr/marusbed)during the initial submission process in order to act appropriately on authorship rights and to prevent ghost or gift authorship.



Clinical and Experimental Health Sciences requires the authors to disclose any existing or potential conflicts of interests, including financial, any financial grants or other support received for a submitted study from individuals or institutions should be disclosed to the Editorial Board. To disclose above mentioned conflict of interests, Conflictof Interest Disclosure Form (available for download at https://dergipark.org.tr/marusbed) should be filled in and submitted. Cases of a potential conflict of interest of the editors, authors, or reviewers are resolved by the journal’s Editorial Board within the scope of COPE and ICMJE guidelines.





When submitting a manuscript to Clinical and Experimental Health Sciences, authors accept to assign the copyright of their manuscript to Marmara University Health Sciences Institute. If rejected for publication, the copyright of the manuscript will be assigned back to the authors. Clinical and Experimental Health Sciences requires each submission to be accompanied by a Copyright Transfer Form (available for download at https://dergipark.org.tr/marusbed). When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).



MANUSCRIPT PREPARATION



The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations updated in December 2018). Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, STROBE guidelines for observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, and TREND guidelines for non-randomized public behavior.



Manuscripts should be prepared in Word file format and can only be submitted through the https://dergipark.org.tr/marusbed submission and evaluation system. Manuscripts submitted via any other format will not be evaluated.



Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests.



Organization of the manuscript



Title page: A separate title page should be submitted with all submissions and this page should include:



- The full title of the manuscript as well as a short title (running title) of no more than 50 characters,

- Name(s), affiliations

- Grant information and detailed information on the other sources of support,

- Name, address, telephone (including the mobile phone number) and email address of the corresponding author,

- Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria.



Abstract: Abstract should be submitted with all manuscript types except for Letters to the Editor. The abstract of Research Articles should be structured with subheadings (Objective, Methods, Results, and Conclusion). Please check Table 1 below for word count specifications.



Keywords: Each submission must be accompanied by a minimum of three to a maximum of five keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).



Manuscript Types



Research Articles: The main text of original articles should be structured with Abstract, Introduction, material and Methods, Results, Discussion, and Conclusion subheadings. Please check Table 1 for the limitations for Research Articles.



Statistical analyses must be conducted in accordance with international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983; 7:1489-1493). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.



Units should be prepared in accordance with the International System of Units (SI).



Review Articles: Reviews prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed. These authors may even be invited by the journal. Reviews should describe, discuss, and evaluate the current level of knowledge of a topic in health sciences and should guide future studies. Please check Table 1 for the limitations for Review Articles.



Case Reports: There is limited space for case reports in the journal and reports on rare cases or conditions that constitute challenges in diagnosis and treatment, those offering new therapies or revealing knowledge not included in the literature, and interesting and educative case reports are accepted for publication. The text should include Abstract, Introduction, Case Presentation, Discussion, and Conclusion subheadings. Please check Table 1 for the limitations for Case Reports.



Letters to the Editor: This type of manuscript discusses important parts, overlooked aspects, or lacking parts of a previously published article. Articles on subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases, may also be submitted in the form of a “Letter to the Editor.” Readers can also present their comments on the published article in the form of a “Letter to the Editor.” Abstract, Keywords, and Tables, Figures, Images, and other media should not be included. The text should be unstructured. The article that is being commented on must be properly cited within this manuscript.



Editorial Comments: Editorial comments aim to provide a brief critical commentary by reviewers with expertise or with high reputation in the topic of the research article published in the journal. Authors are selected and invited by the journal to provide such comments. Abstract, Keywords, and Tables, Figures, Images, and other media are not included.



Table 1. Limitations for each manuscript type

Type of Manuscript



Word Limit (Main Text Only)



Abstract Word Limit



Reference Limit



Table Limit



Figure Limit

Research Article



3500



250 (Structed)



50



6



7 or total

of 15 images



Review Article



500



250



100



6



10 or total

of 20 images



Case Report



1000



200



15



No tables



Total

of 10 images

Letter to the Editor



500



N/A



5



No tables



No media

Headings and subheadings (According to APA)

No heading is needed for the first part of a paper as it is already assumed as the introduction.

Headings and subheadings are not accompanied by letters or numbers.

Use as many levels as required in your paper to present the most organized structure.

The same level of heading or subheading should be of equal importance regardless of the number of subsections under it.

Use at least two subheadings for each section and subsection, or use none.

Start with level 1 through 5.

Paragraph begins below levels 1 and 2, whereas for levels 3-5, the paragraph begins in line with the headings.

Capitalize each word for levels 1 and 2.

Only the first word is capitalized for levels 3-5.

Tables

Tables should be included in the main document, presented after the reference list, and they should be numbered consecutively in the order they are referred within the main text. A descriptive title must be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.

Figures and Figure Legends

Figures, graphics, and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should be labeled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 600 DPI. To prevent delays in the evaluation process, all submitted figures should be clear in resolution and large in size (minimum dimensions: 100× 100 mm). Figure legends should be listed at the end of the main document.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the first time use of the definition.

When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in USA) should be provided in parentheses in the following format: “Discovery PET/CT scanner (General Electric, Milwaukee, WI, USA)”



All figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text.

References

While citing publications, preference should be given to the latest, most up- to-date publications. Only if an ahead-of-print publication is cited, the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ MEDLINE/PubMed. All authors of the cited articles should be listed at the references section. In the main text of the manuscript, references should be numbered based on the appearance order in the main text and should be cited using numbers in parentheses. The reference styles for different types of publications are presented in the following examples.

Journal Article: Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983; 7:1489-1493.


Book Section: Suh KN, Keystone JS. Malaria and babesiosis. Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious Diseases. Philadelphia: Lippincott Williams; 2004.p.2290-2308.


Books: Sweetman SC. Martindale the Complete Drug Reference. 34th ed. London: Pharmaceutical Press; 2005.


Conference Proceedings: Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. pp.1561-1565.


Scientific or Technical Report: Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, et al. Early Treatment Diabetic Retinopathy Study Research Group. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Kidney Int: 2004. Report No: 26.


Thesis: Yılmaz B. Ankara Üniversitesindeki Öğrencilerin Beslenme Durumları, Fiziksel Aktiviteleri ve Beden Kitle İndeksleri Kan Lipidleri Arasındaki Ilişkiler. HacettepeÜniversitesi. Sağlık Bilimleri Enstitüsü, Doktora Tezi. 2007.


Epub Ahead of Print Articles: Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn Interv Radiol. 2016 Feb 24. doi: 10.5152/dir.2016.15323. [Epub ahead of print].


Manuscripts Published in Electronic Format: Morse SS. Factors in the emer- gence of infectious diseases. Emerg Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5): 1(1): (24 screens). Available from: URL: http:/ www.cdc.gov/ ncidodlElD/cid.htm.



REVISIONS

When submitting a revised version of a paper, corresponding author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and page and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 15 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 15-day period is over.

Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed, it is published online on the journal’s webpage as an ahead-of-print publication before it is included in its scheduled issue. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within 2 days of their receipt of the proof.


Note: The abbreviated version of the journal is Clin Exp Health Sci.